Diabetes Self-Management Blog

Diane Fennell

Diane Fennell

Diane Fennell has been an editor at Diabetes Self-Management magazine since 2003. She is currently the Web Editor for Diabetes Self-Management E-News and DiabetesSelfManagement.com.


New Weekly Type 2 Diabetes Drug Approved

On September 18, the US Food and Drug Administration (FDA) approved the once-weekly injectable Type 2 diabetes medicine dulaglutide (brand name Trulicity), developed by Eli Lilly and Company. Trulicity is a new member of the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists

Continue reading this entry

Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications

New research from Denmark has raised the possibility that taking the cholesterol-lowering medicines known as statins may reduce the risk of microvascular diabetes complications, or those involving the small blood vessels…

Continue reading this entry

Antibiotics Linked to Lows in People Taking Certain Diabetes Drugs

A new study from researchers at the University of Texas has linked certain antibiotics to hypoglycemia (low blood glucose) in older people taking sulfonylureas

Continue reading this entry

Low-Carb Diet Benefits Type 2 Diabetes, Heart Health, Studies Show

Eating a low-carbohydrate diet can have benefits for both Type 2 diabetes and heart health, according to two studies recently published in the journals Diabetes Care and Annals of Internal Medicine, respectively…

Continue reading this entry

Pistachios Offer Protection for People With Diabetes

A small new study from Penn State University suggests that pistachios may improve heart health in people who have Type 2 diabetes by reducing the body’s cardiovascular responses to everyday stress…

Continue reading this entry

New Approach for Neuropathy Pain?

Based on the results of a small, ongoing, randomized trial presented at the American Association of Diabetes Educators 2014 Annual Meeting & Exhibition, a low-fat, plant-based diet may be able to control the pain caused by neuropathy.

Continue reading this entry

New Metformin Combo Drug Approved for Type 2 Diabetes

On August 8, the U.S. Food and Drug Administration approved the oral combination medicine canagliflozin/metformin (brand name Invokamet) for Type 2 diabetes. Invokamet is the first medicine to combine an SGLT2 inhibitor and metformin available in the United States…

Continue reading this entry

FDA Approves New Oral Drug for Type 2 Diabetes

On August 1, the FDA approved the oral diabetes drug Jardiance for use, along with a healthful diet and exercise, in adults with Type 2 diabetes. The medicine joins Invokana and Farxiga as a member of the class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors…

Continue reading this entry

Shift Work Tied to Increased Type 2 Diabetes Risk

Shift work is linked to an increased risk of developing Type 2 diabetes, according to new research from China. An estimated 25.8 million people in the United States and 108 million people in China now have Type 2…

Continue reading this entry

High-Salt Diet Doubles Heart Risk in Type 2 Diabetes

People with Type 2 diabetes who eat a high-sodium diet have twice the risk of developing cardiovascular disease as those who consume less salt, according to new research published in The Journal of Clinical Endocrinology and Metabolism…

Continue reading this entry

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.